The goals of the M.S. program in translational biomedicine are to:
- promote interaction and collaboration among researchers across the spectrum of biomedicine;
- enrich translational vocabulary and an understanding of T1 research (laboratory), T2 research (application to evidence-based practice), T3 research (implementation and dissemination), and T4 research (population studies and policy development) among basic, clinical, and human studies scientists; and
- develop skills in ethical decision making, scientific leadership, team building, networking, and research program management.
The Master of Science program in translational biomedicine (TBM) requires a minimum of 30 s.h. of graduate credit plus a final project. Students must maintain a cumulative graduate g.p.a. of at least 3.00 in all UI course work. The plan of study for students in the two-year program is based on their chosen discipline.
The program is designed to teach members of scientific teams how to move biomedical discoveries into clinical applications and beyond. It is tailored for individuals who have completed doctoral-level training in one area of biomedicine and wish to apply their expertise to the T1-T4 research spectrum. The program admits individuals who hold medical or graduate degrees (e.g., M.D., D.O., D.D.S., D.N.P., Ph.D., Pharm.D., D.V.M., or the equivalent) and are employed by the University of Iowa at the faculty ranks of associate professor, assistant professor, instructor, a fellow physician, or a postdoctoral scholar/fellow.
The M.S. with a major in translational biomedicine requires the following course work.
|All of these:|
|TBM:5000||Translational Biomedical Research||9|
|TBM:5001||Introduction to Translational Biomedicine||3|
|TBM:5002||Critical Thinking and Communication: Study Design and Commercialization||1|
|TBM:5003||Critical Thinking and Communication: Scientific Writing and Presentation Strategies||1|
|TBM:5004||Critical Thinking and Communication: Career Development and the Funding Process||1|
|TBM:5005||Critical Thinking and Communication: Leadership, Team Science, and Mentoring||1|
|BIOS:4120||Introduction to Biostatistics||3|
|EPID:4400||Epidemiology I: Principles||3|
|EPID:6950||Clinical Research Ethics||2|
Students must earn a minimum of 6 s.h. in graduate-level elective course work pertinent to their educational goals and background. Electives may be selected from the lists below, or students may obtain approval for other courses with program administration approval.
|EPID:5241||Statistical Methods in Epidemiology||4|
|EPID:5500||Introduction to Clinical Epidemiology||3|
|EPID:5610||Intermediate Epidemiology Data Analysis with SAS and R||3|
|EPID:5900||Problems and Special Topics in Epidemiology||arr.|
|EPID:6100||Writing a Grant Proposal||3|
|EPID:6150||Writing for Medical Journals||1|
|EPID:6250||Genetics and Epidemiology||3|
|EPID:6400||Epidemiology II: Advanced Methods||4|
|EPID:6650||Cardiovascular Disease Epidemiology||3|
|EPID:6900||Design of Intervention and Clinical Trials||3|
|PCOL:5136||Pharmacogenetics and Pharmacogenomics||1|
|PCOL:6250||Advanced Problem Solving in Pharmacological Sciences||1|
|PHAR:5512||Drug Discovery and Mechanisms||3|
|ENTR:9400||Evaluating Innovation Opportunities||2-3|
|ENTR:9550||Commercializing New Technology||3|
|LAW:9717||Iowa Medical Innovation Group Seminar||arr.|
|NURS:6553||Seminar on Innovations||4|
|BME:5210||Medical Imaging Physics||3|
|BME:5220||Digital Image Processing||3|
|BME:5230||Multidimensional Medical Imaging Process||3|
|BME:5401||Biomaterials and Implant Design||3|
|BME:5520||Cardiovascular Fluid Mechanics||3|
|BME:5530||Design of Circulatory Implants and Artificial Organs||3|
|BME:5550||Cardiovascular Tissue Mechanics||3|
|NSCI:5210||Fundamentals of Behavioral Neuroscience||3-4|
|NSCI:5365||Seminar: Neuropsychology and Neuroscience||arr.|
|NSCI:6250||Functional Magnetic Resonance Imaging||2-3|
|NSCI:7235||Neurobiology of Disease||3|
|PSY:6280||Structural and Functional MRI Methods and Application||3|
|PSY:6370||Principles of Neuropsychology||3|
|ACB:6200||Special Topics in Genetics||1|
|GENE:6150||Genetic Analysis of Biological Systems||3|
|GENE:6234||Basic Biostatistical Methods with Genetics Applications||1|
|GENE:7191||Human Molecular Genetics||3|
Informatics and Biostatistics
|BIOS:5120||Regression Modeling and ANOVA in the Health Sciences||3|
|BIOS:5710||Biostatistical Methods I||4|
|BIOS:5720||Biostatistical Methods II||4|
|BIOS:5730||Biostatistical Methods in Categorical Data||3|
|BIOS:6110||Applied Categorical Data Analysis||3|
|BIOS:6210||Applied Survival Analysis||3|
|BIOS:6310||Introductory Longitudinal Data Analysis||3|
|BIOS:6420||Survey Design and Analysis||3|
|BIOS:6610||Statistical Methods in Clinical Trials||3|
|BIOS:6720||Statistical Machine Learning for Biomedical and Public Health Data||3|
|BIOS:6810||Bayesian Methods and Design||3|
|BIOS:7230||Advanced Clinical Trials||3|
|BIOS:7600||Advanced Biostatistics Seminar||0-3|
|EPID:5200||Principles of Public Health Informatics||3|
In addition to completion of the 30 s.h. in required course work, scholars must submit a final project. The project may be in one of the following formats.
- A complete grant application for a K01, K08, K23, K08, R01, R03, R21, or a U.S. Department of Veterans Affairs career award. The R03 completed as part of the required grant writing course may not be submitted as the final project.
- An original research manuscript (less than 2,500 words) of a published or in publishable quality for a peer-reviewed journal. The manuscript must contain the following components:
a structured abstract;
an introductory section that adequately frames the research question addressed; and
a methodology section that sufficiently describes the following elements (study design, study sample, data collection strategies and sources, data elements, and data analysis), results of the study, and a discussion including a description of the relationship of the current findings to prior relevant research and/or policy implications of the findings and methodological limitations.
The Translational Biomedicine Program welcomes applicants who have diverse educational and scientific backgrounds and varied research interests. Applicants must have a strong interest and background in a health science profession and knowledge of basic sciences and medicine.
Applicants must meet the admission requirements of the Graduate College; see the Manual of Rules and Regulations of the Graduate College.
Translational biomedicine applicants must:
- have a doctoral-level degree in a biomedical discipline (e.g., M.D., D.O., D.D.S., D.N.P., Ph.D., Pharm.D., D.V.M., or the equivalent);
- be employed by the University of Iowa as an associate professor, assistant professor, instructor, a fellow physician, or a postdoctoral scholar/fellow;
- be engaged in scientific research with a University of Iowa mentor who has funding from a peer-reviewed source (e.g. National Institutes of Health, National Science Foundation, another foundation, and so forth);
- hold a bachelor's degree from a regionally accredited American college or university or an equivalent degree from an international institution, as determined by the University of Iowa Office of Admissions;
- have a g.p.a. of at least 3.00 or the international equivalent, as determined by the University of Iowa Office of Admissions; and
- have a Graduate Record Exam (GRE) General Test combined verbal and quantitative score of 300 on the revised test (or 1050 on the old test) and an analytical writing score of 4.0 or above; applicants who already hold a graduate or professional degree may seek a waiver of the GRE requirement.
Applicants whose first language is not English must score at least 100 (Internet-based) on the Test of English as a Foreign Language (TOEFL), or they must have a score of at least 7.0, with no subscore lower than 6.0, on the International English Language Testing System (IELTS).
Applicants must submit a curriculum vitae, a statement of research interest and career goals, and three letters of recommendation. One letter must be from the applicant’s UI research mentor; the program recommends that the second be a letter of support from the applicant’s department chair.
All prospective students, and their mentors, must guarantee that once they are accepted as students in the program, they will be able to devote essentially all of their time over a two-year period to training. For instance, a fellow in the Carver College of Medicine might spend no more than two months each year working on clinical assignments (e.g., two months of inpatient assignments or one month of inpatient assignments and one-half day per week in a clinic).